跳至主要内容
临床试验/NCT05386706
NCT05386706已完成不适用

Treating Polycystic Ovarian Syndrome (PCOS) With Digital Intervention vs. Metformin

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年6月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Homeostasis model assessment of insulin resistance

研究概览

简要总结

With the change in environment and lifestyle, and the improvement of people's understanding of PCOS, the incidence of PCOS is increasing worldwide. According to statistics, the prevalence of PCOS in premenopausal women is as high as 5-20%. Lifestyle interventions are the main treatment option for patients with PCOS. In addition, research has shown that digital therapy can effectively improve behavior changes in diet, exercise, and medication adherence, predict disease progression, reduce the frequency of disease-related symptoms, and promote effective disease management. This study aimed to investigate the efficacy of digital intervention versus traditional metformin monotherapy in patients with PCOS.

详细描述

This study developed a mini-program that combined diet, exercise, sleep, and mood interventions for PCOS women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged 18- 45; Meet Rotterdam criteria; Insulin Resistance

排除标准

  • Women who are pregnant or have a pregnancy plan within six months; Congenital adrenocortical hyperplasia; Hyperprolactinemia; Hyperthyroidism or hypothyroidism; Abnormal liver function (≥ 3 times the upper limit of the normal range); Abnormal renal function (GFR<60ml/min/1.73m2); Adrenal or ovarian tumors secreting androgens; Used contraceptives, metformin, pioglitazone, and antidepressant medication in the last 3 months.

研究组 & 干预措施

Digital Intervention

Experimental

A mini program-based digital intervention.

干预措施: Digital Intervention (Behavioral)

Metformin

Active Comparator

Traditional metformin monotherapy.

干预措施: Metformin (Drug)

结局指标

主要结局

Homeostasis model assessment of insulin resistance

时间窗: 3 months

insulin resistance index

次要结局

  • Androstenedione(3 months)
  • free testosterone(3 months)
  • Pittsburgh Sleep Quality Index (PSQI)(3 months)
  • fasting glucose(3 months)
  • fasting insulin(3 months)
  • total testosterone(3 months)
  • Total cholesterol(3 months)
  • menstrual frequency(3 months)
  • Triglycerides(3 months)
  • HDL-c(3 months)
  • LDL-c(3 months)
  • Anthropometry(3 months)
  • Sex hormone-binding globulin(3 months)
  • Dehydroepiandrosterone(3 months)
  • International Physical Activity Questionnaire (IPAQ)(3 months)
  • Hospital Anxiety and Depression Scale (HADS)(3 months)
  • Three-Factor Eating Questionnaire (TFEQ-R21)(3 months)

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhang Manna

Director, Principal Investigator, Clinical Professor

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验